** = Publikationen gelistet in SCI/SSCI/Pubmed
** Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Pichler, A; Fruhwirth, V; Ropele, S; Schmidt, R; Fuchs, S; Enzinger, C
Long-term course and morphological MRI correlates of cognitive function in multiple sclerosis.
Mult Scler. 2021; 27(6):954-963
Doi: 10.1177/1352458520941474
Web of Science
PubMed
FullText
FullText_MUG
** Kober, SE; Pinter, D; Enzinger, C; Damulina, A; Duckstein, H; Fuchs, S; Neuper, C; Wood, G
Self-regulation of brain activity and its effect on cognitive function in patients with multiple sclerosis - First insights from an interventional study using neurofeedback.
Clin Neurophysiol. 2019; 130(11):2124-2131
Doi: 10.1016/j.clinph.2019.08.025
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Bachmaier, G; Enzinger, C; Fazekas, F
The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis.
Mult Scler. 2019; 25(1):48-54
Doi: 10.1177/1352458517736149
Web of Science
PubMed
FullText
FullText_MUG
** Pinter, D; Beckmann, CF; Fazekas, F; Khalil, M; Pichler, A; Gattringer, T; Ropele, S; Fuchs, S; Enzinger, C
Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function.
Sci Rep. 2019; 9(1):16221-16221
Doi: 10.1038/s41598-019-52757-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Walleczek, NK; Frommlet, F; Bsteh, G; Eggers, C; Rauschka, H; Koppi, S; Assar, H; Ehling, R; Birkl, C; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Buchinger, D; Sellner, J; Kraus, J; Moser, H; Mayr, M; Guger, M; Rathmaier, S; Raber, B; Liendl, H; Hiller, MS; Parigger, S; Morgenstern, G; Kempf, I; Spiss, HK; Meister, B; Heine, M; Cisar, A; Bachler, H; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Leutmezer, F; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F
Month-of-birth-effect in multiple sclerosis in Austria.
Mult Scler. 2019; 25(14):1870-1877
Doi: 10.1177/1352458518810924
Web of Science
PubMed
FullText
FullText_MUG
** Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C
Diagnosis and monitoring of MS associated neurocognitive disorder: tests, assessment tools, computer interface etc
MULT SCLER J. 2019; 25(8):NP12-NP12.-Annual Meeting of the International-Multiple-Sclerosis-Cognition-Society (IMSCOGS); JUN 06-07, 2019; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
** Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C
The evolution of cognitive function in MS over ten years and the association with MRI findings
MULT SCLER J. 2019; 25: 400-401.-35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS; SEP 11-13, 2019; Stockholm, SWEDEN.
[Oral Communication]
Web of Science
** Stryeck, S; Voortman, M; Enzinger, C; Fuchs, S; Deisenhammer, F; Hegen, H; Fazekas, F; Madl, T; Khalil, M
Serum NMR spectroscopy metabolomic profiles indicate progressive multiple sclerosis
EUR J NEUROL. 2019; 26: 241-241.
[Poster]
Web of Science
** Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M
The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2018; 4(3):2055217318800810-2055217318800810
Doi: 10.1177/2055217318800810
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M
Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Poster]
Web of Science
** Pichler, A; Hochstrasser, D; Khalil, M; Langkammer, C; Pirpamer, L; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
The effect of smoking on 'normal appearing white matter' and lesion load in periventricular regions of patients with multiple sclerosis
MULT SCLER J. 2018; 24: 582-582.
[Poster]
Web of Science
** Schoonheim, MM; Pinter, D; Meijer, KA; Eijlers, AJC; Pirpamer, L; Khalil, M; Pichler, A; Fuchs, S; Fazekas, F; Uitdehaag, BMJ; Barkhof, F; Enzinger, C; Geurts, JJG
Specific patterns of thalamic functional connectivity changes related to disability and cognitive impairment in multiple sclerosis
MULT SCLER J. 2018; 24: 613-614.
[Poster]
Web of Science
** Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
** Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M
The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY.
[Poster]
Web of Science
FullText
** Moser, AM; Spindelboeck, W; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Högenauer, C; Khalil, M
Mucosal biopsy shows immunologic changes of the colon in patients with early MS.
Neurol Neuroimmunol Neuroinflamm. 2017; 4(4):e362-e362
Doi: 10.1212/NXI.0000000000000362
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Voortman, MM; Pekar, T; Bachmayer, D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.
Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317727294-2055217317727294
Doi: 10.1177/2055217317727294
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Mult Scler. 2017; 23(11):1496-1505
Doi: 10.1177/1352458516681503
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
** Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M
Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
** Kober, SE; Pinter, D; Fuchs, S; Neuper, C; Fazekas, F; Enzinger, C; Wood, G
Train Your Brain: Neurofeedback for Cognitive Rehabilitation in Multiple Sclerosis
MULT SCLER J. 2017; 23(6):882-882.-22nd Annual RIMS Conference on Shaping the Future of MS Rehabilitation; MAY 04-06, 2017; Barcelona, SPAIN.
[Poster]
Web of Science
** Pinter, D; Beckmann, C; Fazekas, F; Khalil, M; Pichler, A; Ropele, S; Fuchs, S; Enzinger, C
Morphologic MRI phenotyping of multiple sclerosis associates with altered brain function
MULT SCLER J. 2017; 23: 539-540.
[Poster]
Web of Science
** Pinter, D; Fazekas, F; Damulina, A; Pirpamer, L; Pichler, A; Khalil, M; Ropele, S; Fuchs, S; Enzinger, C
Evolution of cognitive function in MS and its relationship to physical disability and MRI metrics
MULT SCLER J. 2017; 23: 285-286.
[Poster]
Web of Science
** Pinter, D; Pirpamer, L; Damulina, A; Fazekas, F; Pichler, A; Khalil, M; Fuchs, S; Enzinger, C
Long-term course of cognitive function and disability in patients with MS
MULT SCLER J. 2017; 23(8): NP1-NP1.
[Oral Communication]
Web of Science
** Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS.
[Poster]
Web of Science
FullText
** Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
FullText
** Disanto, G; Adiutori, R; Dobson, R; Martinelli, V; Dalla, Costa, G; Runia, T; Evdoshenko, E; Thouvenot, E; Trojano, M; Norgren, N; Teunissen, C; Kappos, L; Giovannoni, G; Kuhle, J, , International, Clinically, Isolated, Syndrome, Study, Group
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
J Neurol Neurosurg Psychiatry. 2016; 87(2):126-9
Doi: 10.1136/jnnp-2014-309690
Web of Science
PubMed
FullText
FullText_MUG
** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Pichler, A; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Mult Scler. 2016; 22(12):1560-1568
Doi: 10.1177/1352458515624560
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice.
Mult Scler. 2016; 22(3):340-346
Doi: 10.1177/1352458515593405
Web of Science
PubMed
FullText
FullText_MUG
** Pinter, D; Beckmann, C; Koini, M; Pirker, E; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
PLoS One. 2016; 11(3):e0152158-e0152158
Doi: 10.1371/journal.pone.0152158
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kober, SE; Pinter, D; Fuchs, S; Neuper, C; Fazekas, F; Enzinger, C; Wood, G
Neurofeedback as cognitive training tool in multiple sclerosis - a first exploratory study
MULT SCLER J. 2016; 22: 813-814.
Web of Science
** Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in early multiple sclerosis.
MULT SCLER J. 2016; 22: 70-70.-32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, ENGLAND.
[Oral Communication]
Web of Science
** Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C
The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis
MULT SCLER J. 2016; 22: 759-759.
Web of Science
** Pinter, D; Khalil, M; Greiner, P; Moser, D; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C
Lesion filling more strongly affects estimation of grey than white matter volumes in a large patient sample depending on hyperintense lesion load
MULT SCLER J. 2016; 22: 512-512.
Web of Science
** Spindelboeck, W; Moser, AM; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Hogenauer, C; Khalil, M
Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis
MULT SCLER J. 2016; 22: 179-179.
Web of Science
** Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM.
[Poster]
Web of Science
** Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C
Periventricular lesions correlate with cortical thinning in multiple sclerosis.
Ann Neurol. 2015; 78(4): 530-539.
Doi: 10.1002/ana.24461
Web of Science
PubMed
FullText
FullText_MUG
** Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Neurology. 2015; 84(24): 2396-2402.
Doi: 10.1212/WNL.0000000000001679
Web of Science
PubMed
FullText
FullText_MUG
** Kuhle, J; Disanto, G; Dobson, R; Adiutori, R; Bianchi, L; Topping, J; Bestwick, JP; Meier, UC; Marta, M; Dalla Costa, G; Runia, T; Evdoshenko, E; Lazareva, N; Thouvenot, E; Iaffaldano, P; Direnzo, V; Khademi, M; Piehl, F; Comabella, M; Sombekke, M; Killestein, J; Hegen, H; Rauch, S; D'Alfonso, S; Alvarez-Cermeño, JC; Kleinová, P; Horáková, D; Roesler, R; Lauda, F; Llufriu, S; Avsar, T; Uygunoglu, U; Altintas, A; Saip, S; Menge, T; Rajda, C; Bergamaschi, R; Moll, N; Khalil, M; Marignier, R; Dujmovic, I; Larsson, H; Malmestrom, C; Scarpini, E; Fenoglio, C; Wergeland, S; Laroni, A; Annibali, V; Romano, S; Martínez, AD; Carra, A; Salvetti, M; Uccelli, A; Torkildsen, Ø; Myhr, KM; Galimberti, D; Rejdak, K; Lycke, J; Frederiksen, JL; Drulovic, J; Confavreux, C; Brassat, D; Enzinger, C; Fuchs, S; Bosca, I; Pelletier, J; Picard, C; Colombo, E; Franciotta, D; Derfuss, T; Lindberg, R; Yaldizli, Ö; Vécsei, L; Kieseier, BC; Hartung, HP; Villoslada, P; Siva, A; Saiz, A; Tumani, H; Havrdová, E; Villar, LM; Leone, M; Barizzone, N; Deisenhammer, F; Teunissen, C; Montalban, X; Tintoré, M; Olsson, T; Trojano, M; Lehmann, S; Castelnovo, G; Lapin, S; Hintzen, R; Kappos, L; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, SV; Giovannoni, G
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Mult Scler. 2015; 21(8):1013-1024
Doi: 10.1177/1352458514568827
Web of Science
PubMed
FullText
FullText_MUG
** Penner, IK; Sivertsdotter, EC; Celius, EG; Fuchs, S; Schreiber, K; Berkö, S; Svenningsson, A; TYNERGY trial investigators
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
Front Neurol. 2015; 6(3):18-18
Doi: 10.3389/fneur.2015.00018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pinter, D; Khalil, M; Pichler, A; Langkammer, C; Ropele, S; Marschik, PB; Fuchs, S; Fazekas, F; Enzinger, C
Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
Neuroimage Clin. 2015; 7(4):715-720
Doi: 10.1016/j.nicl.2015.02.023
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C
Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
MULT SCLER J. 2015; 21: 180-181.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
Doi: 10.1177/135245851560
[Poster]
Web of Science
FullText
FullText_MUG
** Jehna, M; Pirpamer, L; Khalil, M; Stulnig, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Deutschmann, H; Fazekas, F; Enzinger, C
Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
EUR J NEUROL. 2015; 22: 155-155.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY.
[Poster]
Web of Science
FullText
** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
** Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
** Walleczek, NK; Rauschka, H; Bsteh, G; Birkl, CB; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Eggers, C; Leutmezer, F; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Koppi, S; Sellner, J; Kraus, J; Assar, H; Gugger, M; Ehling, R; Moser, H; Raber, B; Liendl, H; Parigger, S; Mayr, M; Hiller, MS; Meister, B; Morgenstern, G; Spiess, HK; Kempf, I; Cisar, A; Bachler, H; Lehninger, R; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F
Month-of-birth-effect in multiple sclerosis in Austria
MULT SCLER J. 2015; 21: 102-103.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
** Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Mult Scler. 2014; 20(12):1569-1577
Doi: 10.1177/1352458514530020
Web of Science
PubMed
FullText
FullText_MUG
** Loitfelder, M; Fazekas, F; Koschutnig, K; Fuchs, S; Petrovic, K; Ropele, S; Pichler, A; Jehna, M; Langkammer, C; Schmidt, R; Neuper, C; Enzinger, C
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
PLoS One. 2014; 9(4):e93715-e93715
Doi: 10.1371/journal.pone.0093715
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C
Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis.
PLoS One. 2014; 9(1):e87567-e87567
Doi: 10.1371/journal.pone.0087567
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Enzinger, C (presented on behalf of Khalil M); Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F;
Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 58-58. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014)
[Oral Communication]
Web of Science
** Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study
J NEUROL. 2014; 261: S43-S43.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY.
[Oral Communication]
Web of Science
** Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F
Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging
J NEUROL. 2014; 261: S44-S44.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY.
[Oral Communication]
Web of Science
** Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F;
Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 59-59. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014)
[Oral Communication]
Web of Science
** Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C
The default mode network: the resting-state network most sensitive for cerebral functional changes over short-term in multiple sclerosis
J NEUROL. 2014; 261: S248-S248.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY.
[Poster]
Web of Science
** Pinter, D; Beckmann, C; Loitfelder, M; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C;
The default mode network - the resting-state network most sensitive for cerebral functional changes over short-term in multiple sclerosis.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 369-369. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014)
[Poster]
Web of Science
** Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
Dynamics of brain iron accumulation differ between clinically isolated syndrome and definite multiple sclerosis: a longitudinal 3T MRI study
Multiple Sclerosis Journal - 2014 Joint Actrims-Ectrims Meeting (MS Boston 2014). 2014; 20(S1):269-269.-MS Boston 2014 - Joint ACTRIMS-ECTRIMS Meeting; SEP 10-13, 2014; Boston, USA.
[Poster]
Web of Science
FullText
** Aboul-Enein, F; Seifert-Held, T; Mader, S; Kuenz, B; Lutterotti, A; Rauschka, H; Rommer, P; Leutmezer, F; Vass, K; Flamm-Horak, A; Stepansky, R; Lang, W; Fertl, E; Schlager, T; Heller, T; Eggers, C; Safoschnik, G; Fuchs, S; Kraus, J; Assar, H; Guggenberger, S; Reisz, M; Schnabl, P; Komposch, M; Simschitz, P; Skrobal, A; Moser, A; Jeschow, M; Stadlbauer, D; Freimüller, M; Guger, M; Schmidegg, S; Franta, C; Weiser, V; Koppi, S; Niederkorn-Duft, M; Raber, B; Schmeissner, I; Jecel, J; Tinchon, A; Storch, MK; Reindl, M; Berger, T; Kristoferitsch, W
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.
PLoS One. 2013; 8(11):e79649-e79649
Doi: 10.1371/journal.pone.0079649
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fazekas, C; Khalil, M; Enzinger, C; Matzer, F; Fuchs, S; Fazekas, F
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Clin Neurol Neurosurg. 2013; 115(3):293-297
Doi: 10.1016/j.clineuro.2012.05.022
Web of Science
PubMed
FullText
FullText_MUG
** Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Reishofer, G; Fazekas, F; Ebner, F; Enzinger, C
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in multiple sclerosis.
Brain Connect. 2013; 3(3):255-264
Doi: 10.1089/brain.2012.0108
PubMed
FullText
FullText_MUG
** Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Trentini, A; Vane, ML; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Koel-Simmelink, MJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Mult Scler. 2013; 19(4):436-442
Doi: 10.1177/1352458512458010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S
Quantitative susceptibility mapping in multiple sclerosis.
Radiology. 2013; 267(2):551-559
Doi: 10.1148/radiol.12120707
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, A; Enzinger, C; Fuchs, S; Plecko-Startinig, B; Gruber-Sedlmayr, U; Linortner, P; Langkammer, C; Khalil, M; Ebner, F; Ropele, S; Fazekas, F
Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis.
Mult Scler. 2013; 19(2):167-172
Doi: 10.1177/1352458512448107
Web of Science
PubMed
FullText
FullText_MUG
** Preiningerova, JL; Baumhackl, U; Csepany, T; Czaplinski, A; Deisenhammer, F; Derfuss, T; Fabjan, TH; Fazekas, F; Fuchs, S; Havrdova, E; Ledinek, AH; Illes, Z; Jazbec, SS; Klimova, E; Komoly, S; Kurca, E; Linnebank, M; Lisy, L; Mares, J; Prochazkova, L; Csilla, R; Szilasiova, J; Stourac, P; Talab, R; Turcani, P; Vachova, M; Vecsei, L; Vodusek, D; Zapletalova, O; Berger, T
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).
CNS Neurosci Ther. 2013; 19(5):302-306
Doi: 10.1111/cns.12101
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Svenningsson, A; Falk, E; Celius, EG; Fuchs, S; Schreiber, K; Berkö, S; Sun, J; Penner, IK; Tynergy Trial Investigators
Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.
PLoS One. 2013; 8(3):e58643-e58643
Doi: 10.1371/journal.pone.0058643
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545.
[Poster]
Web of Science
** Kuhle, J; Dobson, R; Bestwick, JP; Topping, J; Dalla Costa, G; Khademi, M; Sombekke, M; Killestein, J; Evdoshenko, E; Lazareva, N; Runia, T; Zbornikova, P; Horakova, D; D'Alfonso, S; Thouvenot, E; Moll, N; Hegen, H; Rauch, S; Khalil, M; Fuchs, S; Lindberg, RLP; Derfuss, T; Llufriu, S; Franciotta, D; Roesler, R; Lauda, F; Rajda, C; Drulovic, J; Menge, T; Kieseier, BC; Avsar, T; Marignier, R; Malmestrom, C; Myhr, KM; Wergeland, S; Annibali, V; Romano, S; Carra, A; Laroni, A; Frederiksen, JL; Larsson, HB; Uccelli, A; Martinez, AD; Salvetti, M; Torkildsen, O; Lycke, J; Confavreux, C; Rejdak, K; Bosca, I; Brassat, D; Scarpini, E; Fenoglio, C; Galimberti, D; Siva, A; Hartung, HP; Dujmovic, I; Vecsei, L; Tumani, H; Bergamaschi, R; Colombo, E; Villoslada, P; Saiz, A; Enzinger, C; Kappos, L; Deisenhammer, F; Alvarez-Cermeno, JC; Villar, L; Pelletier, J; Lehmann, S; Castelnovo, G; Barizzone, N; Leone, M; Havrdova, E; Trojano, M; Iaffaldano, P; Direnzo, V; Comabella, M; Tintore, M; Montalban, X; Hintzen, R; Lapin, S; Teunissen, C; Piehl, F; Olsson, T; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, S; Giovannoni, G
Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
MULT SCLER J. 2013; 19(11): 33-34.
[Oral Communication]
Web of Science
** Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C
Educational attainment moderates the effect of T2 lesion load and thalamic atrophy on cognition in multiple sclerosis
MULT SCLER J. 2013; 19(11): 437-438.
[Poster]
Web of Science
** Loitfelder, M; Filippi, M; Rocca, M; Valsasina, P; Ropele, S; Jehna, M; Fuchs, S; Schmidt, R; Neuper, C; Fazekas, F; Enzinger, C
Abnormalities of resting state functional connectivity are related to sustained attention deficits in MS.
PLoS One. 2012; 7(8):e42862-e42862
Doi: 10.1371/journal.pone.0042862
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schmied, MC; Zehetmayer, S; Reindl, M; Ehling, R; Bajer-Kornek, B; Leutmezer, F; Zebenholzer, K; Hotzy, C; Lichtner, P; Meitinger, T; Wichmann, HE; Illig, T; Gieger, C; Huber, K; Khalil, M; Fuchs, S; Schmidt, H; Auff, E; Kristoferitsch, W; Fazekas, F; Berger, T; Vass, K; Zimprich, A
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.
Neurogenetics. 2012; 13(2):181-187
Doi: 10.1007/s10048-012-0316-y
Web of Science
PubMed
FullText
FullText_MUG
** Svenningsson, A; Celius, E; Schreiber, K; Fuchs, S; Falk, E; Berko, S; Moller, CM; Penner, IK
Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) - First Results from the TYNERGY Trial
NEUROLOGY. 2012; 78: -64th Annual Meeting of the American-Academy-of-Neurology (AAN); APR 21-28, 2012; New Orleans, LA.
[Poster]
Web of Science
** Enzinger, C; Fuchs, S; Pichler, A; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F
Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data.
Mult Scler. 2011; 17(6): 695-701.
Doi: 10.1177/1352458510394454
Web of Science
PubMed
FullText
FullText_MUG
** Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Fuchs, S; Khalil, M; Pluta-Fuerst, A; Fazekas, F; Enzinger, C
Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces.
Brain Imaging Behav. 2011; 5(4): 241-251.
Doi: 10.1007/s11682-011-9128-1
Web of Science
PubMed
FullText
FullText_MUG
** Jehna, M; Neuper, C; Ischebeck, A; Loitfelder, M; Ropele, S; Langkammer, C; Ebner, F; Fuchs, S; Schmidt, R; Fazekas, F; Enzinger, C
The functional correlates of face perception and recognition of emotional facial expressions as evidenced by fMRI.
Brain Res. 2011; 1393(5):73-83
Doi: 10.1016/j.brainres.2011.04.007
Web of Science
PubMed
FullText
FullText_MUG
** Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Bachmaier, G; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
Mult Scler. 2011; 17(2): 173-180.
Doi: 10.1177/1352458510384009
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Khalil, M; Langkammer, C; Ropele, S; Petrovic, K; Wallner-Blazek, M; Loitfelder, M; Jehna, M; Bachmaier, G; Schmidt, R; Enzinger, C; Fuchs, S; Fazekas, F
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.
Neurology. 2011; 77(18): 1691-1697.
Doi: 10.1212/WNL.0b013e318236ef0e
Web of Science
PubMed
FullText
FullText_MUG
** Kincses, ZT; Ropele, S; Jenkinson, M; Khalil, M; Petrovic, K; Loitfelder, M; Langkammer, C; Aspeck, E; Wallner-Blazek, M; Fuchs, S; Jehna, M; Schmidt, R; Vécsei, L; Fazekas, F; Enzinger, C
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
Mult Scler. 2011; 17(6): 681-689.
Doi: 10.1177/1352458510391342
Web of Science
PubMed
FullText
FullText_MUG
** Loitfelder, M; Fazekas, F; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Khalil, M; Schmidt, R; Neuper, C; Enzinger, C
Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI.
Neurology. 2011; 76(6): 526-533.
Doi: 10.1212/WNL.0b013e31820b75cf
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pluta-Fuerst, A; Petrovic, K; Berger, T; Fryze, W; Fuchs, S; Gold, R; Kozubski, W; Ladurner, G; Petereit, H; Potemkowski, A; Rieckmann, P; Sailer, M; Szczudlik, A; Vass, K; Weber, T; Zakrzewska-Pniewska, B; Fazekas, F
Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish study.
Mult Scler. 2011; 17(4): 478-486.
Doi: 10.1177/1352458510391341
Web of Science
PubMed
FullText
FullText_MUG
** Ropele, S; Langkammer, C; Enzinger, C; Fuchs, S; Fazekas, F
Relaxation time mapping in multiple sclerosis.
Expert Rev Neurother. 2011; 11(3): 441-450.
Doi: 10.1586/ern.10.129
Web of Science
PubMed
FullText
FullText_MUG
** Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C
Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
J NEUROL. 2011; 258: 154-154.
[Poster]
Web of Science
** Loitfelder, M; Fazekas, F; Aspeck, E; Jehna, M; Ropele, S; Fuchs, S; Wallner-Blazek, M; Pichler, A; Petrovic, K; Vollmann, R; Neuper, C; Schmidt, R; Enzinger, C
Evidence for resource allocation of the brain to preserve cognitive function with progression of relapsing-remitting multiple sclerosis-Insights from a longitudinal fMRI study
J NEUROL. 2011; 258: 153-154.
[Poster]
Web of Science
** Fazekas, F; Baumhackl, U; Berger, T; Deisenhammer, F; Fuchs, S; Kristoferitsch, W; Ladurner, G; Soukop, W; Wimmer, G; Vass, K
Decision-making for and impact of early immunomodulatory treatment: the Austrian Clinically Isolated Syndrome Study (ACISS)
EUR J NEUROLOGY. 2010; 17(6): 852-860.
Doi: 10.1111/j.1468-1331.2009.02943.x
Web of Science
FullText
FullText_MUG
** Giorgio, A; Palace, J; Johansen-Berg, H; Smith, SM; Ropele, S; Fuchs, S; Wallner-Blazek, M; Enzinger, C; Fazekas, F
Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.
J Magn Reson Imaging. 2010; 31(2): 309-316.
Doi: 10.1002/jmri.22062
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Jehna, M; Neuper, C; Petrovic, K; Wallner-Blazek, M; Schmidt, R; Fuchs, S; Fazekas, F; Enzinger, C
An exploratory study on emotion recognition in patients with a clinically isolated syndrome and multiple sclerosis.
Clin Neurol Neurosurg. 2010; 112(6): 482-484.
Doi: 10.1016/j.clineuro.2010.03.020
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, C; Khalil, M; Enzinger, C; Fuchs, S; Fazekas, F
Attachment style and temperament in people with early stages of multiple sclerosis
J PSYCHOSOM RES. 2010; 68(6): 47
[Poster]
Web of Science
** Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F
Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Mult Scler. 2009; 15(9): 1048-1054.
Doi: 10.1177/1352458509106609
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, F; Enzinger, C; Wallner-Blazek, M; Ropele, S; Pluta-Fuerst, A; Fuchs, S
Gender differences in MRI studies on multiple sclerosis.
J Neurol Sci. 2009; 286(1-2): 28-30.
Doi: 10.1016/j.jns.2009.07.025
Web of Science
PubMed
FullText
FullText_MUG
** Enzinger, C; Loitfelder, M; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Schmidt, R; Neuper, C; Fazekas, F
Functional reorganisation in cognitive networks with disease progression in multiple sclerosis.
MULT SCLER. Multiple Sclerosis2009; 15(9):S222-S222.-25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS); SEPT 9-12, 2009; Duesseldorf, GERMANY.
[Poster]
Web of Science
** Jehna, M; Loitfelder, M; Neuper, C; Fuchs, S; Ropele, S; Langkammer, C; Schmidt, R; Fazekas, F; Enzinger, C
A new fMRI paradigm to study the recognition process of emotional facial expression in multiple sclerosis.
MULT SCLER. Multiple Sclerosis2009; 15(9):S222-S222.-25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9-12, 2009; Duesseldorf, GERMANY.
[Poster]
Web of Science
** Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
The Spectrum of Cognitive Impairment and Its Relation to Brain Morphology Including Iron Deposition in Multiple Sclerosis.
NEUROLOGY. 2009; 72(11):A142-A142.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2, 2009; Seattle, USA.
[Poster]
Web of Science
** Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
Cognitive impairment in patients with a clinically isolated syndrome - correlation with MRI parameters including magnetization transfer imaging.
MULT SCLER. 2009; 15(9):S227-S228.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 912, 2009; Düsseldorf, GERMANY.
[Poster]
Web of Science
** Grabner, R; Popotnig, F; Ropele, S; Neuper, C; Gorani, F; Petrovic, K; Ebner, F; Strasser-Fuchs, S; Fazekas, F; Enzinger, C
Brain activation patterns elicited by the 'Faces Symbol Test' -- a pilot fMRI study.
Mult Scler. 2008; 14(3): 354-363.
Doi: 10.1177/1352458507084030
Web of Science
PubMed
FullText
FullText_MUG
** Strasser-Fuchs, S; Enzinger, C; Ropele, S; Wallner, M; Fazekas, F
Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
Mult Scler. 2008; 14(2): 205-211.
Doi: 10.1177/1352458507082354
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Enzinger, C; Loitfelder, M; Ropele, S; Neuper, C; Petrovic, K; Aspeck, E; Fuchs, S; Fazekas, F
Evidence for cortical reorganisation in cognitive domains in multiple sclerosis: insights from a 'Go/NoGo' Task.
Multiple Sclerosis2008; 14(S1):S103-S103.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEP 17-20, 2008; Montreal, CANADA.
[Poster]
Web of Science
** Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna. M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
Executive dysfunction represents an underestimated component of cognitive impairment in multiple sclerosis.
Multiple Sclerosis2008; 14(S1):S258-S259.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEPT 17-20, 2008; Montreal, CANADA.
[Poster]
Web of Science
** Fazekas, F; Strasser-Fuchs, S; Hommes, OR
Intravenous immunoglobulin in MS: promise or failure?
J Neurol Sci. 2007; 259(1-2):61-66
Doi: 10.1016/j.jns.2006.12.018
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Baumhackl, U; Berger, T; Deisenhammer, E; Fazekas, F; Kristoferitsch, W; Ladumer, G; Soukop, W; Strasser-Fuchs, S; Vass, K; Wimmer, G
The Austrian clinically isolated syndrome study (ACISS): baseline results
MULT SCLER. 2007; 13: S104-S105.-23rd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 11-14, 2007; Prague, CZECH REPUBLIC.
[Oral Communication]
Web of Science
** Fazekas, F; Enzinger, C; Ropele, S; Schmidt, H; Schmidt, R; Strasser-Fuchs, S
The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
J NEUROL SCI. 2006; 245(1-2): 35-39.
Doi: 10.1016/j.jns.2005.08.018
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wallner, M; Enzinger, C; Ropele, S; Strasser-Fuchs, S; Fazekas, F
Non-conventional MRI measures of brain tissue integrity fail to explain the preservation of function in some MS patients with an extensive lesion load but a benign course of the disease
MULT SCLER. 2006; 12: S179-S179.-22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis; SEP 27-30, 2006; Madrid, SPAIN.
[Poster]
Web of Science
** Enzinger, C; Strasser-Fuchs, S; Ropele, S; Kapeller, P; Kleinert, R; Fazekas, F
Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging.
MULT SCLER. 2005; 11: 135-139.
Doi: 10.1191/1352http://dx.doi.org/10.1191/1352458505ms1145oa
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kapeller, P; Ropele, S; Enzinger, C; Lahousen, T; Strasser-Fuchs, S; Schmidt, R; Fazekas, F
Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy.
J NEUROL. 2005; 252(10): 1229-1234.
Doi: 10.1007/s00415-005-0847-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Seifert, T; Enzinger, C; Ropele, S; Storch, MK; Strasser-Fuchs, S; Fazekas, F
Relapsing acute transverse myelitis: a specific entity.
EUR J NEUROLOGY. 2005; 12: 681-684.
Doi: 10.1111/j.1468-1331.2005.01007.x
Web of Science
PubMed
FullText
FullText_MUG
** Enzinger, C; Ropele, S; Strasser-Fuchs, S; de Stefano, N; Matthews, P; Kapeller, P; Smith, S; Fazekas, F
Progressive brain tissue loss and reduction of N-acetylaspartate despite immunomodulatory therapy in relapsing-remitting multiple sclerosis: results of a longitudinal single-centre study analysing MR spectroscopic, brain volume and focal tissue changes
J NEUROL 2005 252: 91-91.
Web of Science
** Ehling, R; Gassner, Ch; Lutterotti, A; Strasser-Fuchs, S; Kollegger, H; Kristoferitsch, W; Reindl, M; Berger, T
Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis.
Tissue Antigens. 2004; 63(1):28-33
Doi: 10.1111/j.1399-0039.2004.00166.x
Web of Science
PubMed
FullText
FullText_MUG
** Enzinger, C; Ropele, S; Smith, S; Strasser-Fuchs, S; Poltrum, B; Schmidt, H; Matthews, PM; Fazekas, F
Accelerated evolution of brain atrophy and black holes in MS patients with APOE-epsilon 4.
ANN NEUROL. 2004; 55: 563-569.
Doi: 10.1002/ana.20027
Web of Science
PubMed
FullText
FullText_MUG
** Ganzinger, U; Badelt, C; Vass, K; Strasser-Fuchs, S; Fazekas, F; Berger, T; Dahlke, F
Health care costs of multiple sclerosis in Austria. Cross-sectional study including consideration of quality of life
NERVENARZT. 2004; 75(10): 1000-1006.
Doi: 10.1007/s00115-004-1732-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rieckmann, P; Toyka, KV; Bassetti, C; Beer, K; Beer, S; Buettner, U; Chofflon, M; Götschi-Fuchs, M; Hess, K; Kappos, L; Kesselring, J; Goebels, N; Ludin, HP; Mattle, H; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Freimüller, M; Kollegger, H; Kristoferitsch, W; Lassmann, H; Markut, H; Strasser-Fuchs, S; Vass, K; Altenkirch, H; Bamborschke, S; Baum, K; Benecke, R; Brück, W; Dommasch, D; Elias, WG; Gass, A; Gehlen, W; Haas, J; Haferkamp, G; Hanefeld, F; Hartung, HP; Heesen, C; Heidenreich, F; Heitmann, R; Hemmer, B; Hense, T; Hohlfeld, R; Janzen, RW; Japp, G; Jung, S; Jügelt, E; Koehler, J; Kölmel, W; König, N; Lowitzsch, K; Manegold, U; Melms, A; Mertin, J; Oschmann, P; Petereit, HF; Pette, M; Pöhlau, D; Pohl, D; Poser, S; Sailer, M; Schmidt, S; Schock, G; Schulz, M; Schwarz, S; Seidel, D; Sommer, N; Stangel, M; Stark, E; Steinbrecher, A; Tumani, H; Voltz, R; Weber, F; Weinrich, W; Weissert, R; Wiendl, H; Wiethölter, H; Wildemann, U; Zettl, UK; Zipp, F; Zschenderlein, R; Izquierdo, G; Kirjazovas, A; Packauskas, L; Miller, D; Koncan Vracko, B; Millers, A; Orologas, A; Panellus, M; Sindic, CJ; Bratic, M; Svraka, A; Vella, NR; Stelmasiak, Z; Selmaj, K; Bartosik-Psujik, H; Mitosek-Szewczyk, K; Belniak, E; Mochecka, A; Bayas, A; Chan, A; Flachenecker, P; Gold, R; Kallmann, B; Leussink, V; Mäurer, M; Ruprecht, K; Stoll, G; Weilbach, FX; Multiple Sclerosis Therapy Consensus Group
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
J Neurol. 2004; 251(11):1329-1339
Doi: 10.1007/s00415-004-0537-6
Web of Science
PubMed
FullText
FullText_MUG
** Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Kristoferitsch, W; Ladurner, G; Soukop, W; Strasser-Fuchs, S; Vass, K
Austrian clinically isolated syndrome study (ACISS): methodology and first baseline data
MULT SCLER 2004 10: S176-S176.
Web of Science
** Enzinger, C; Ropele, S; Strasser-Fuchs, S; Matthews, P; Kapeller, R; Smith, S; Fazekas, F
A combined longitudinal MRI analysis assessing spectroscopic, brain volume and focal brain tissue changes suggests a limited effect of immunomodulatory agents on the progression of relapsing-remitting multiple sclerosis
MULT SCLER 2004 10: S223-S223.
[Poster]
Web of Science
** Auer-Grumbach, M; Strasser-Fuchs, S; Robl, T; Windpassinger, C; Wagner, K
Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene.
Neurology. 2003; 61(10):1435-1437
Doi: 10.1212/01.WNL.0000094197.46109.75
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Enzinger, C; Ropele, S; Strasser-Fuchs, S; Kapeller, P; Schmidt, H; Poltrum, B; Schmidt, R; Hartung, HP; Fazekas, F
Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
Arch Neurol. 2003; 60(1):65-70
Doi: 10.1001/archneur.60.1.65
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, F; Ropele, S; Enzinger, C; Seifert, T; Strasser-Fuchs, S
Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis.
Mult Scler. 2002; 8(6):479-484
Doi: 10.1191/1352458502ms860oa
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Kieseier, BC; Niederwieser, G; Hartung, HP; Archelos, JJ
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neurology. 2002; 59(7):990-997
Doi: 10.1212/WNL.59.7.990
Web of Science
PubMed
FullText
FullText_MUG
** Seifert, T; Kieseier, BC; Ropele, S; Strasser-Fuchs, S; Quehenberger, F; Fazekas, F; Hartung, HP
TACE mRNA expression in peripheral mononudear cells precedes new lesions on MRI in multiple sclerosis.
MULT SCLER 2002 8: 447-451.
Doi: 10.1191%2F1352458502ms830oa
Web of Science
PubMed
FullText
FullText_MUG
** Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Hartung, HP; Archelos, JJ
Multiple sclerosis: Immunologic effects of statins in vitro: A new therapeutic approach?
NEUROLOGY 2002 58: A73-A73.
Web of Science
** Fazekas, F; Strasser-Fuchs, S; Kollegger, H; Berger, T; Kristoferitsch, W; Schmidt, H; Enzinger, C; Schiefermeier, M; Schwarz, C; Kornek, B; Reindl, M; Huber, K; Grass, R; Wimmer, G; Vass, K; Pfeiffer, KH; Hartung, HP; Schmidt, R
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
Neurology. 2001; 57(5):853-857
Doi: 10.1212/WNL.57.5.853
Web of Science
PubMed
FullText
FullText_MUG
** Krametter, D; Niederwieser, G; Berghold, A; Birnbaum, G; Strasser-Fuchs, S; Hartung, HP; Archelos, JJ
Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
Mult Scler. 2001; 7(1):13-18
Doi: 10.1191%2F135245801676514804
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Krametter, D; Niederwieser, G; Berghold, A; Birnbaum, G; Strasser-Fuchs, S; Hartung, HP; Archelos, JJ
Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis.
ANN NEUROL. 2001; 49(1): 135-135.
Doi: 10.1002%2F1531-8249%28200101%2949%3A1%3C135%3A%3AAID-ANA23%3E3.0.CO%3B2-T
Web of Science
PubMed
FullText
FullText_MUG
** Seifert, T; Kieseier, BC; Ropele, S; Strasser-Fuchs, S; Fazekas, F; Hartung, HP
Tumor necrosis factor-alpha-converting enzyme mRNA expression in peripheral mononuclear cells precedes lesion appearance on MRI in relapsing-remitting multiple sclerosis
NEUROLOGY 2001 56: A294-A294.
Web of Science
** Auer-Grumbach, M; Wagner, K; Strasser-Fuchs, S; Löscher, WN; Fazekas, F; Millner, M; Hartung, HP
Clinical predominance of proximal upper limb weakness in CMT1A syndrome.
Muscle Nerve. 2000; 23(8):1243-1249
Doi: 10.1002%2F1097-4598%28200008%2923%3A8%3C1243%3A%3AAID-MUS13%3E3.0.CO%3B2-Z
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bammer, R; Augustin, M; Strasser-Fuchs, S; Seifert, T; Kapeller, P; Stollberger, R; Ebner, F; Hartung, HP; Fazekas, F
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis.
Magn Reson Med. 2000; 44(4):583-591
Doi: 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bammer, R; Fazekas, F; Augustin, M; Simbrunner, J; Strasser-Fuchs, S; Seifert, T; Stollberger, R; Hartung, HP
Diffusion-weighted MR imaging of the spinal cord.
AJNR Am J Neuroradiol. 2000; 21(3):587-591
[OPEN ACCESS]
Web of Science
PubMed
FullText
** Fazekas, F; Strasser-Fuchs, S; Schmidt, H; Enzinger, C; Ropele, S; Lechner, A; Flooh, E; Schmidt, R; Hartung, HP
Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2000; 69(1):25-28
Doi: 10.1136%2Fjnnp.69.1.25
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Ropele, S; Strasser-Fuchs, S; Augustin, M; Stollberger, R; Enzinger, C; Hartung, HP; Fazekas, F
A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis.
AJNR Am J Neuroradiol. 2000; 21(10):1885-1891
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar
** Strasser-Fuchs, S; Fazekas, F
Immunoglobulin in neurologic disorders
AKTUEL NEUROL. 2000; 27: 268-272.
Doi: 10.1055/s-2007-1017553
Web of Science
FullText
FullText_MUG
** Auer-Grumbach, M; Fazekas, F; Radner, H; Irmler, A; Strasser-Fuchs, S; Hartung, HP
Troyer syndrome: a combination of central brain abnormality and motor neuron disease?
J Neurol. 1999; 246(7):556-561
Doi: 10.1007%2Fs004150050403
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Deisenhammer, F; Fazekas, F; Strasserfuchs, S; Nahler, G; Mamoli, B
Intravenous Immunoglobulins in Multiple-Sclerosis - Results of the Austrian Immunoglobulin in Multiple-Sclerosis (Aims) Trial
INFUSIONSTHERAPIE 1999 26: 42-47.
Doi: 10.1159/000053538
Web of Science
FullText
FullText_MUG
** Auer-Grumbach, M; Wagner, K; Fazekas, F; Löscher, WN; Strasser-Fuchs, S; Hartung, HP
Hereditary motor-sensory neuropathies (Charcot-Marie-Tooth syndrome) and related neuropathies. Current classification and genotype-phenotype correlation
Nervenarzt. 1999; 70(12):1052-1061
Doi: 10.1007/s001150050539
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Auer-Grumbach, M; Strasser-Fuchs, S; Wagner, K; Körner, E; Fazekas, F
Roussy-Lévy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2.
J Neurol Sci. 1998; 154(1):72-75
Doi: 10.1016/S0022-510X(97)00218-9
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, F; Roob, G; Payer, F; Kapeller, P; Strasser-Fuchs, S; Aigner, RM
Technetium-99m-ECD SPECT fails to show focal hyperemia of acute herpes encephalitis.
J Nucl Med. 1998; 39(5):790-792
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
Google Scholar
** Fazekas, F; Strasser-Fuchs, S; Hartung, HP
Intravenous immunoglobulins in therapy of intermittent multiple sclerosis. An update
Nervenarzt. 1998; 69(4):361-365
Doi: 10.1007/s001150050284
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, F; Deisenhammer, F; Strasser-Fuchs, S; Nahler, G; Mamoli, B
Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: further analyses of the Austrian Immunoglobulin in MS study.
MULT SCLER. 1997; 3(2): 137-141.
Doi: 10.1177/135245859700300214
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fazekas, F; Deisenhammer, F; Strasser-Fuchs, S; Nahler, G; Mamoli, B
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.
Lancet. 1997; 349(9052):589-593
Doi: 10.1016/S0140-6736(96)09377-4
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Strasser-Fuchs, S; Fazekas, F; Flooh, E; Kapeller, P; Poltrum, B; Offenbacher, H
Attitude of patients with multiple sclerosis to illness information
NERVENARZT. 1997; 68(12): 963-966.
Doi: 10.1007/s001150050223
Web of Science
PubMed
FullText
FullText_MUG
** Auer-Grumbach, M; Wagner, K; Strasser-Fuchs, S; Millner, M; Fazekas, F
Charcot-Marie-Tooth syndrome. Clinico-genetic correlation in an affected family
Nervenarzt. 1996; 67(2):155-159
Web of Science
PubMed
Google Scholar
** Fazekas, F; Offenbacher, H; Schmidt, R; Strasser-Fuchs, S
MRI of neuromyelitis optica: evidence for a distinct entity.
J Neurol Neurosurg Psychiatry. 1994; 57(9):1140-1142
Doi: 10.1136/jnnp.57.9.1140
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kainz, JT; Soyer, HP; Strasser-Fuchs, S; Smolle, J
Acquired naevus flammeus (Fegeler syndrome)
HAUTARZT. 1991; 42: 289-292.
(- Case Report)
Web of Science
PubMed
Google Scholar
** Fazekas, F; Offenbacher, H; Fuchs, S; Schmidt, R; Niederkorn, K; Horner, S; Lechner, H
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.
Neurology. 1988; 38(12):1822-1825
Doi: 10.1212/WNL.38.12.1822
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fuchs, S; Pogglitsch, H; Ladurner, G; Lechner, H
Plasmapheresis in multiple sclerosis
Wien Klin Wochenschr. 1984; 96(2):67-69
Web of Science
PubMed
Google Scholar
** Enge, S; Körner, K; Fuchs, S; Ladurner, G; Schneider, G; Lechner, H
Electroencephalographic and computer tomography findings in vascular epilepsy of ischemic origin
EEG-EMG-Z ELEKTROENZ ELEKTROM. 1983; 14(4): 191-194.
Doi: 10.1055/s-2008-1061051
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar